Spruce Biosciences, Inc. (SPRB)
NASDAQ: SPRB · Real-Time Price · USD
58.83
+0.43 (0.74%)
At close: Mar 23, 2026, 4:00 PM EDT
60.00
+1.17 (1.99%)
After-hours: Mar 23, 2026, 4:59 PM EDT

Spruce Biosciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
81931711926105
Market Cap Growth
443.76%437.50%-85.46%361.35%-75.29%-81.46%
Enterprise Value
3784-3916-5819
Last Close Price
58.4087.1131.50219.7582.31334.50
PS Ratio
--3.5311.82--
PB Ratio
1.882.190.601.560.380.94
P/TBV Ratio
2.012.190.601.560.380.94
EV/Sales Ratio
---1.62--
Debt / Equity Ratio
0.020.020.100.060.090.06
Net Debt / Equity Ratio
-1.13-1.13-1.25-1.20-1.06-0.74
Net Debt / EBITDA Ratio
1.691.690.641.771.541.96
Net Debt / FCF Ratio
1.451.450.642.761.752.29
Asset Turnover
--0.070.11--
Quick Ratio
5.115.112.543.946.3510.03
Current Ratio
5.175.172.904.186.7210.36
Return on Equity (ROE)
-109.24%-109.24%-100.70%-66.10%-51.35%-32.43%
Return on Assets (ROA)
-36.41%-36.41%-47.06%-34.28%-27.86%-18.17%
Return on Capital Employed (ROCE)
-66.60%-66.60%-187.40%-65.40%-64.60%-35.80%
Earnings Yield
-45.56%-41.79%-305.73%-40.17%-178.61%-40.41%
FCF Yield
-38.97%-35.74%-322.61%-27.90%-161.25%-34.37%
Buyback Yield / Dilution
-39.34%-39.34%-7.14%-63.68%-0.71%-289.93%
Updated Mar 9, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.